Prostate cancer gene 3 urine assay cutoff in diagnosis of prostate cancer

A validation study on an Italian patient population undergoing first and repeat biopsy

Enrico Bollito, Stefano De Luca, Matteo Cicilano, Roberto Passera, Susanna Grande, Carmen Maccagnano, Susanna Cappia, Angela Milillo, Francesco Montorsi, Roberto Mario Scarpa, Mauro Papotti, Donato Franco Randone

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective: To determine an optimal prostate cancer gene 3 (PCA3) cutoff in predicting prostate cancer in Italian patients undergoing first or repeat biopsy. Study design: In this observational multicenter study 1,246 men with elevated prostate specific antigen (PSA) and negative digital rectal examination, with prostate biopsy after PCA3 assessment, were divided into two groups submitted to PCA3 testing before or after previous negative biopsies. Ideal PCA3 cutoff was identified using area under the curve of the receiver operating characteristic analysis. Various cutoff values were used to determine the best predictive score. Univariate and multivariate logistic regression models compared age, PSA, free-PSA, and PCA3 score to predict prostate cancer. Results: PCA3 cutoff 39-50 had the highest accuracy in the repeat biopsy group in which cutoff of 39 could have avoided 51.9% negative repeat biopsies, eventually missing 7.8% of cancers (all low risk); cutoff of 50 would have prevented 56.5% of negative repeat biopsies, missing 29 tumors (10.3%), 5 potentially aggressive. The PCA3 test performed poorly in the first biopsy group. Conclusion: We confirm the usefulness of PCA3 in Italian men with a previous negative biopsy. We achieved the best performance at a cutoff of 39. PCA3 did not perform better than PSA in non-biopsy-selected men.

Original languageEnglish
Pages (from-to)96-104
Number of pages9
JournalAnalytical and Quantitative Cytology and Histology
Volume34
Issue number2
Publication statusPublished - Apr 2012

Fingerprint

Validation Studies
Neoplasm Genes
Prostatic Neoplasms
Urine
Biopsy
Population
Prostate-Specific Antigen
Logistic Models
Digital Rectal Examination
ROC Curve
Multicenter Studies
Area Under Curve
Observational Studies
Prostate
Neoplasms

Keywords

  • Diagnostic method
  • PCA3
  • Prostate cancer
  • Prostate specific antigen
  • Sensitivity
  • Specificity

ASJC Scopus subject areas

  • Anatomy
  • Histology

Cite this

Prostate cancer gene 3 urine assay cutoff in diagnosis of prostate cancer : A validation study on an Italian patient population undergoing first and repeat biopsy. / Bollito, Enrico; De Luca, Stefano; Cicilano, Matteo; Passera, Roberto; Grande, Susanna; Maccagnano, Carmen; Cappia, Susanna; Milillo, Angela; Montorsi, Francesco; Scarpa, Roberto Mario; Papotti, Mauro; Randone, Donato Franco.

In: Analytical and Quantitative Cytology and Histology, Vol. 34, No. 2, 04.2012, p. 96-104.

Research output: Contribution to journalArticle

Bollito, E, De Luca, S, Cicilano, M, Passera, R, Grande, S, Maccagnano, C, Cappia, S, Milillo, A, Montorsi, F, Scarpa, RM, Papotti, M & Randone, DF 2012, 'Prostate cancer gene 3 urine assay cutoff in diagnosis of prostate cancer: A validation study on an Italian patient population undergoing first and repeat biopsy', Analytical and Quantitative Cytology and Histology, vol. 34, no. 2, pp. 96-104.
Bollito, Enrico ; De Luca, Stefano ; Cicilano, Matteo ; Passera, Roberto ; Grande, Susanna ; Maccagnano, Carmen ; Cappia, Susanna ; Milillo, Angela ; Montorsi, Francesco ; Scarpa, Roberto Mario ; Papotti, Mauro ; Randone, Donato Franco. / Prostate cancer gene 3 urine assay cutoff in diagnosis of prostate cancer : A validation study on an Italian patient population undergoing first and repeat biopsy. In: Analytical and Quantitative Cytology and Histology. 2012 ; Vol. 34, No. 2. pp. 96-104.
@article{8b474a13c3c74e57a486c49d05423440,
title = "Prostate cancer gene 3 urine assay cutoff in diagnosis of prostate cancer: A validation study on an Italian patient population undergoing first and repeat biopsy",
abstract = "Objective: To determine an optimal prostate cancer gene 3 (PCA3) cutoff in predicting prostate cancer in Italian patients undergoing first or repeat biopsy. Study design: In this observational multicenter study 1,246 men with elevated prostate specific antigen (PSA) and negative digital rectal examination, with prostate biopsy after PCA3 assessment, were divided into two groups submitted to PCA3 testing before or after previous negative biopsies. Ideal PCA3 cutoff was identified using area under the curve of the receiver operating characteristic analysis. Various cutoff values were used to determine the best predictive score. Univariate and multivariate logistic regression models compared age, PSA, free-PSA, and PCA3 score to predict prostate cancer. Results: PCA3 cutoff 39-50 had the highest accuracy in the repeat biopsy group in which cutoff of 39 could have avoided 51.9{\%} negative repeat biopsies, eventually missing 7.8{\%} of cancers (all low risk); cutoff of 50 would have prevented 56.5{\%} of negative repeat biopsies, missing 29 tumors (10.3{\%}), 5 potentially aggressive. The PCA3 test performed poorly in the first biopsy group. Conclusion: We confirm the usefulness of PCA3 in Italian men with a previous negative biopsy. We achieved the best performance at a cutoff of 39. PCA3 did not perform better than PSA in non-biopsy-selected men.",
keywords = "Diagnostic method, PCA3, Prostate cancer, Prostate specific antigen, Sensitivity, Specificity",
author = "Enrico Bollito and {De Luca}, Stefano and Matteo Cicilano and Roberto Passera and Susanna Grande and Carmen Maccagnano and Susanna Cappia and Angela Milillo and Francesco Montorsi and Scarpa, {Roberto Mario} and Mauro Papotti and Randone, {Donato Franco}",
year = "2012",
month = "4",
language = "English",
volume = "34",
pages = "96--104",
journal = "Analytical and Quantitative Cytology",
issn = "0884-6812",
publisher = "Science Printers and Publishers Inc.",
number = "2",

}

TY - JOUR

T1 - Prostate cancer gene 3 urine assay cutoff in diagnosis of prostate cancer

T2 - A validation study on an Italian patient population undergoing first and repeat biopsy

AU - Bollito, Enrico

AU - De Luca, Stefano

AU - Cicilano, Matteo

AU - Passera, Roberto

AU - Grande, Susanna

AU - Maccagnano, Carmen

AU - Cappia, Susanna

AU - Milillo, Angela

AU - Montorsi, Francesco

AU - Scarpa, Roberto Mario

AU - Papotti, Mauro

AU - Randone, Donato Franco

PY - 2012/4

Y1 - 2012/4

N2 - Objective: To determine an optimal prostate cancer gene 3 (PCA3) cutoff in predicting prostate cancer in Italian patients undergoing first or repeat biopsy. Study design: In this observational multicenter study 1,246 men with elevated prostate specific antigen (PSA) and negative digital rectal examination, with prostate biopsy after PCA3 assessment, were divided into two groups submitted to PCA3 testing before or after previous negative biopsies. Ideal PCA3 cutoff was identified using area under the curve of the receiver operating characteristic analysis. Various cutoff values were used to determine the best predictive score. Univariate and multivariate logistic regression models compared age, PSA, free-PSA, and PCA3 score to predict prostate cancer. Results: PCA3 cutoff 39-50 had the highest accuracy in the repeat biopsy group in which cutoff of 39 could have avoided 51.9% negative repeat biopsies, eventually missing 7.8% of cancers (all low risk); cutoff of 50 would have prevented 56.5% of negative repeat biopsies, missing 29 tumors (10.3%), 5 potentially aggressive. The PCA3 test performed poorly in the first biopsy group. Conclusion: We confirm the usefulness of PCA3 in Italian men with a previous negative biopsy. We achieved the best performance at a cutoff of 39. PCA3 did not perform better than PSA in non-biopsy-selected men.

AB - Objective: To determine an optimal prostate cancer gene 3 (PCA3) cutoff in predicting prostate cancer in Italian patients undergoing first or repeat biopsy. Study design: In this observational multicenter study 1,246 men with elevated prostate specific antigen (PSA) and negative digital rectal examination, with prostate biopsy after PCA3 assessment, were divided into two groups submitted to PCA3 testing before or after previous negative biopsies. Ideal PCA3 cutoff was identified using area under the curve of the receiver operating characteristic analysis. Various cutoff values were used to determine the best predictive score. Univariate and multivariate logistic regression models compared age, PSA, free-PSA, and PCA3 score to predict prostate cancer. Results: PCA3 cutoff 39-50 had the highest accuracy in the repeat biopsy group in which cutoff of 39 could have avoided 51.9% negative repeat biopsies, eventually missing 7.8% of cancers (all low risk); cutoff of 50 would have prevented 56.5% of negative repeat biopsies, missing 29 tumors (10.3%), 5 potentially aggressive. The PCA3 test performed poorly in the first biopsy group. Conclusion: We confirm the usefulness of PCA3 in Italian men with a previous negative biopsy. We achieved the best performance at a cutoff of 39. PCA3 did not perform better than PSA in non-biopsy-selected men.

KW - Diagnostic method

KW - PCA3

KW - Prostate cancer

KW - Prostate specific antigen

KW - Sensitivity

KW - Specificity

UR - http://www.scopus.com/inward/record.url?scp=84860998056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860998056&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 96

EP - 104

JO - Analytical and Quantitative Cytology

JF - Analytical and Quantitative Cytology

SN - 0884-6812

IS - 2

ER -